- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03770143
Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance
April 22, 2019 updated by: Merih Cetinkaya, Kanuni Sultan Suleyman Training and Research Hospital
Depending on recent studies in literature the investigators aimed to compare whether gastrointestinal tolerance differs between infants fed with palm olein containing or palm olein free formulas.
Besides it is showed that palm olein containing formulas decreases the absorption of fat and calcium by forming insoluble calcium soaps.
So it is suggested that intestinal flora might be affected as a reason of these specialties.
This study also aimed to investigate with culture-independent methods whether feeding infants with palm olein free formula results in the modification of their intestinal microbiota in such a way that is similar to breastfed ones.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Recent studies in literature the investigators aimed to compare whether gastrointestinal tolerance differs between infants fed with palm olein containing or palm olein free formulas.
Besides it is showed that palm olein containing formulas decreases the absorption of fat and calcium by forming insoluble calcium soaps.
So it is suggested that intestinal flora might be affected as a reason of these specialties.
This study also aimed to investigate with culture-independent methods whether feeding infants with palm olein free formula results in the modification of their intestinal microbiota in such a way that is similar to breastfed ones.
Study Type
Observational
Enrollment (Actual)
90
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kucukcekmece
-
Istanbul, Kucukcekmece, Turkey, 34303
- Kanuni Sultan Suleyman Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 3 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
A total of 90 healthy infants (30 under breast-feeding, 30 feeding with palm olein free formula and 30 feeding with palm olein formula) will be included.
Infants feeding enterally more than %70 with breast milk will be considered as breast-feeding.
Infants who had not adequate weight gain and need formula will be randomized to receive either palm olein or palm olein free term formula in addition to mother milk.
Parental informed consent will be taken and infants whose parents give permission will be included.
Description
Inclusion Criteria:
The data of the patients who fulfilled the following criteria are evaluated.
Term infants between 38 and 40 weeks of gestational age and/or with a birth weight of > 2500grams who are either breastfed or formula fed.
Selection of the subgroup using oral nutrition
- Feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life
- Feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life Selection of the subgroup not using oral nutritional supplement (control group)
- Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)
Exclusion Criteria:
- Infants with major congenital abnormalities will be excluded.
- Infants with lack of data will also be excluded.
- Infants, whose parents don't agree with informed consent, will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
Infants feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life
|
|
|
Group 2
Infants feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life
|
|
|
Group 3
Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stool consistency
Time Frame: 10 weeks
|
Amsterdam Infant Stool Scale
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bacteria Count
Time Frame: 10 weeks
|
number of the copy of DNA of Intestinal Flora Content
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Seda Yilmaz Semerci, Kanuni SSTRH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2016
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
May 11, 2016
First Submitted That Met QC Criteria
December 6, 2018
First Posted (Actual)
December 10, 2018
Study Record Updates
Last Update Posted (Actual)
April 23, 2019
Last Update Submitted That Met QC Criteria
April 22, 2019
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ANCL034
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Bacteria Flora Disturbance
-
Da VolterraCompletedIntestinal Bacteria Flora DisturbanceFrance
-
DOMCA S.A.CompletedIntestinal Bacteria Flora DisturbanceSpain
-
TCI Co., Ltd.CompletedIntestinal Bacteria Flora DisturbanceTaiwan
-
University of California, Los AngelesCompletedIntestinal Bacteria Flora DisturbanceUnited States
-
Farmoquimica S.A.CompletedConstipation | Intestinal Bacteria Flora Disturbance
-
The First Affiliated Hospital of Nanchang UniversityCompletedAcute Pancreatitis | Intestinal Bacteria Flora Disturbance | Fecal Microbiota Transplantation | Intestinal DysfunctionChina
-
First Affiliated Hospital of Chengdu Medical CollegeUnknownAcute Pancreatitis | Intestinal Bacteria Flora Disturbance | Fecal Microbiota Transplantation | Intestinal DysfunctionChina
-
National Cheng-Kung University HospitalNational Science Council, TaiwanUnknownGastrointestinal Function | Intestinal Bacteria FloraTaiwan
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruitingInfections | Helicobacter Pylori Infection | Intestinal Bacteria Flora DisturbanceChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University of Padova; Centers for Disease Control and Prevention; Aga Khan University and other collaboratorsCompletedRotavirus Infections | Reaction - Vaccine Nos | Intestinal Bacteria Flora Disturbance
Clinical Trials on Feeding with palm olein formula
-
Malaysia Palm Oil BoardUnknown
-
Imperial College LondonMalaysia Palm Oil BoardCompletedHealthy VolunteersUnited Kingdom
-
Malaysia Palm Oil BoardCompleted
-
Imperial College LondonMalaysia Palm Oil BoardCompletedLipidaemiaUnited Kingdom
-
Malaysia Palm Oil BoardUniversiti Putra Malaysia; International Medical UniversityCompleted
-
Universiti Kebangsaan Malaysia Medical CentreMalaysia Palm Oil Board; Hovid BerhadNot yet recruitingAlcoholic Fatty Liver DiseaseMalaysia
-
King's College LondonCompletedHealthy Men | Raised Fasting Plasma Triacylglycerol ConcentrationsUnited Kingdom
-
Malaysia Palm Oil BoardUniversiti Putra Malaysia; Ministry of Health, MalaysiaCompletedType 2 Diabetes MellitusMalaysia
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Heinz Italia SpACompletedNutrition | Microbiota | Newborns | Innate ImmunityItaly
-
Malaysia Palm Oil BoardIMU University, MalaysiaActive, not recruiting